Skip to search formSkip to main contentSkip to account menu

EBMT Blade Myeloma 1998 Oncology Response Criteria

Known as: EBMT BLADE MYELOMA 1998 
Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
The use of mobilized peripheral blood (PB) as stem cell source in allogeneic stem cell transplantation (HSCT) from sibling or… 
2014
2014
In this article we suggest guidelines for the diagnostic process with appropriate investigations to be carried out. Part of the… 
2012
2012
Abstract 469 Background: After allogeneic HSCT, graft-versus-host disease (GvHD) occurs through recognition of minor or major… 
2010
2010
Abstract 223 The use of single cord blood unit for transplantation in adult patients is limited due to the high risk of graft… 
Review
2009
Review
2009
Abstract 195 TBI/CY and oral (p.o) Bu/Cy are the traditional allogeneic HSCT (alloHSCT) myeloablative conditioning regimens for… 
2008
2008
Cyclophosphamide (CY) associated to high dose total body irradiation (TBI) or busulfan (BU) is the gold standard of myeloablative… 
2001
2001
One key to the success of EBMT is the removal of the boundaries limiting the potential of translation memories. To bring EBMT to… 
1992
1992
Cancer may be serious late effect of marrow transplantation. Radiation, chemotherapy, immunosuppression and the original disease…